## ALL: Allstate Corporation (The) - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.23 indicates fundamental undervaluation. Quality metrics strong (ROE 34%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($201.70)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Stance Capital LLC Invests $1.30 Million in The Progressive Corporation $PGR**
- Source: MarketBeat | 20251215T115545 | Neutral | Relevance: 65%
- Stance Capital LLC recently acquired a new stake of 4,856 shares in The Progressive Corporation (NYSE:PGR), valued at approximately $1.30 million during the second quarter. Other institutional investors have also adjusted their holdings, with the company's stock currently trading at $234.61 with a market cap of $137.58 billion. Analysts currently give Progressive an average "Hold" rating with a consensus price target of $266.40.

**2. Caxton Associates LLP Makes New $1.10 Million Investment in UFP Industries, Inc. $UFPI**
- Source: MarketBeat | 20251216T090834 | Neutral | Relevance: 65%
- Caxton Associates LLP has made a new investment of approximately $1.10 million in UFP Industries, Inc. (NASDAQ:UFPI), acquiring 11,059 shares in the second quarter. This comes as UFP Industries reported a Q2 earnings miss with $1.29 EPS vs $1.37 consensus and revenue of $1.56 billion, down 5.4% year-over-year. Analyst ratings are mixed, with a consensus "Hold" rating and a $114.25 price target.

**3. Chubb's Kelsie Bicking applies product focus to insurtech**
- Source: Digital Insurance | 20251216T200800 | Neutral | Relevance: 62%
- Kelsie Bicking, VP of agent experience at Chubb, leverages her strong product-focused background to enhance the insurer's Marketplace platform for agents. She works on improving agent-facing tools and developing new products by understanding the agents' needs through a "product lens" rather than purely technological one. Her efforts have recently expanded Marketplace to include lower middle-market businesses and incorporate agent feedback into new features.

**4. Is It Too Late To Consider Chubb After Its Strong Multi Year Share Price Run?**
- Source: Simply Wall Street | 20251216T140810 | Somewhat-Bullish | Relevance: 61%
- Chubb has seen significant share price appreciation over the past few years, with a 54% gain over 3 years and 122.5% over 5 years. Despite this, Simply Wall St's valuation framework suggests the stock is currently undervalued, scoring 4 out of 6 checks. The Excess Returns model indicates Chubb is approximately 51.3% undervalued, while its PE ratio of 12.72x is below its calculated Fair Ratio of 13.68x, suggesting modest undervaluation.

**5. Here's Why RenaissanceRe Shares Are Attracting Prudent Investors Now**
- Source: TradingView â€” Track All Markets | 20251215T160936 | Bullish | Relevance: 61%
- RenaissanceRe Holdings Ltd. (RNR) is attracting investors due to its strong performance, including a 10% share growth in six months, increasing net premiums, investment income, and strategic acquisitions. The company also boasts robust cash generation, evident in share buybacks and dividend payouts, and is currently trading at a discount compared to the industry average. Despite these positives, investors should consider risks such as escalating expenses and high debt levels.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $254 | $0 | 0% |
| 2025-12-16 | Morgan Stanley | $215 | $245 | -12% |
| 2025-11-26 | Roth Capital | $240 | $230 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Outperform |
| 2025-12-16 | Morgan Stanley | down | Equal-Weight |
| 2025-11-26 | Roth Capital | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.12M) |
| Sells | 12 ($11.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (-0.3%)
- Blackrock Inc.: 8.5% (-1.0%)
- Price (T.Rowe) Assoc: 4.9% (-17.0%)
- State Street Corpora: 4.5% (+0.7%)
- Geode Capital Manage: 2.7% (+3.3%)

### Key Risks

1. Heavy insider selling: $11M sold (12 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +5.3% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.23 suggests fair value with growth premium. Quality metrics strong (ROE 34%). Balance sheet: strong liquidity (30938000000.0x), $3.2B free cash flow. Insider selling cluster ($11.2M in 90 days), potential headwind. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $55.1B |
| Beta | 0.25 |
| 52W Range | $176.00 - $215.89 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.23 |
| Forward P/E | 8.7 |
| Current P/E | 7.3 |
| YoY Growth | -15.7% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -2.9% to 2.4% (+5.3% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.6pp (needs >4.0% for momentum thesis). MRS_5 at 2.0% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 55. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.40% (CS: 51) | Neutral |
| RSI_14 | 54.8 | Neutral |
| MACD Histogram | 0.01 | Bullish |
| vs SMA20 | 1.003x | Above |
| vs SMA50 | 1.027x | Above |
| vs SMA200 | 1.035x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $209.12
- **Stop Loss:** $201.70 (3.5% risk)
- **Target:** $223.96 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 145
- **Position Value:** $30,322.40
- **Portfolio %:** 30.32%
- **Risk Dollars:** $1,080.00
- **Risk Per Trade:** 1.08%
- **Modifiers:** L1 90% | L2 120% | Combined 1.08x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

**Next:** 2026-02-04 (Est: $8.25)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $7.54 | $11.17 | +48.1% |
| 2025Q2 | $3.26 | $5.94 | +82.4% |
| 2025Q1 | $2.53 | $3.53 | +39.3% |
| 2024Q4 | $6.28 | $7.67 | +22.1% |

---
*RULE-based L3 | 2026-01-07 01:41 | MRS_20*